Compare BioNTech SE - ADR (BNTX) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Nuwellis Inc — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.86B), while Nuwellis Inc trades at $3.16 (market cap $1.17M). The key difference: BioNTech SE - ADR is far larger — about 19538.5× Nuwellis Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | NUWE | |
|---|---|---|
Market Cap | $22.86B | $1.17M |
Sector | Health | Technology |
52-Week High | $119.34 | $558.26 |
52-Week Low | $83.89 | $2.80 |
Enterprise Value | $6.53B | -$636.97K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
